0,1,2,3,4,5,6,7,8,9,10,11,12,13
,Table 3 Clinical management summary of 13 Ebola virus disease patients treated outside West Africa,,,,,,,,,,,,
Reference,[76],[76],[42],"[28, 79, 137]","[78, 79, 82]","[81, 82]",[38],"[25, 77]","[28, 99]",[81],[81],[82],[37]
Demographics,,,,,,,,,,,,,
Gender,M,F,M,M,M,M,M,F,M,F,F,M,M
Age (years),33,59,36,51,43,42,38,44,33,26,29,44,43
Country of,Liberia,Liberia,Sierra Leone,Liberia,Sierra Leone,Liberia,Sierra Leone,Spain,Liberia,USA,USA,Sierra Leone,Sierra Leone
infection,,,,,,,,,,,,,
Country,USA,USA,Germany,USA,USA,USA,Germany,Spain,USA,USA,USA,USA,Switzerland
providing care,,,,,,,,,,,,,
Hospital admission,,,,,,,,,,,,,
Admission date,2 Aug 2014,5 Aug 2014,27 Aug 2014,5 Sep 2014,9 Sep 2014,30 Sep 2014,3 Oct 2014,6 Oct 2014,6 Oct 2014,11 Oct 2014,14 Oct 2014,15 Nov 2014,21 Nov 2014
Days from,7,10,4,7,2,N/A,5,0,5,N/A,N/A,6,4
diagnosis to,,,,,,,,,,,,,
evacuation,,,,,,,,,,,,,
Hospital LOS,19,14,30,20,41,8,47,30,16,13,14,3,15
Vital status,Survived,Survived,Survived,Survived,Survived,Died,Survived,Survived,Survived,Survived,Survived,Died,Survived
Critical care therapies,,,,,,,,,,,,,
"Central
line",N,N,Y,Y,Y,Y,Y,N,Y,Y,N,Y,Y
Vasopressors,N,N,N,N,Y,Y,Y,N,N,N,N,Y,N
Oxygen,Y,Y,Y,Y,Y,Y,Y,Y,N,N,N,Y,N
"NIV (d, days)",N,N,Y (8d),N,N,N,Y (1d),N,N,N,N,N,N
"MV (d, days)",N,N,N,N,Y (17d),Y (5d),Y (13d),N,N,N,N,Y (3d),N
"CRRT (d, days)",N,N,N,N,Y (24d),Y (5d),Y (18d),N,N,N,N,Y (3d),N
"IHD (d, days)",N,N,N,N,N,N,Y (10d),N,N,N,N,N,N
Experimental therapies,,,,,,,,,,,,,
Convalescent,Y,N,N,Y,Y,N,N,Y,Y,Y,Y,Y,N
plasma,,,,,,,,,,,,,
ZMapp/ZMab,Y,Y,N,N,N,N,N,Y,N,Y,N,Y,Y
Brincidofovir,N,N,N,N,N,Y,N,N,Y,Y,Y,N,N
Favipiravir,N,N,Y,N,N,N,Y,Y,N,N,N,N,Y
TKM,N,N,Y,Y,Y,N,N,N,N,Y,N,N,N
Other,N/A,N/A,N/A,N/A,N/A,N/A,"Amiodarone,",N/A,N/A,N/A,N/A,N/A,N/A
,,,,,,,FX06,,,,,,
